logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Genzyme Corporation


USPTO Granted Patents = 823

% Expired Patents = 16.2



Trademarks = 63

Forward Citations = 15,471

Loading Chart...
Loading Chart...

957 inventors (with patents filed for the assignee):

goldMedal Seng H Cheng (54 out of 71 patents)

silverMedal Craig S Siegel (41 out of 42 patents)

bronzeMedal Huawei Qiu (33 out of 47 patents)

4.  David J Harris (32 out of 32 patents)

5.  Clark Qun Pan (32 out of 56 patents)

6.  Alexander Hee-Hanson (31 out of 31 patents)

7.  Robert J Miller (30 out of 30 patents)

8.  Stephen Randall Holmes-Farley (29 out of 76 patents)

9.  Robert Wilson (27 out of 27 patents)

10.  Pradeep K Dhal (25 out of 40 patents)

11.  Edward R Lee (25 out of 30 patents)

12.  Thomas Lever (25 out of 25 patents)

13.  James E Stefano (23 out of 29 patents)

14.  Bradford Hirth (23 out of 34 patents)

15.  Luis Z Avila (21 out of 38 patents)


Core Competencies:
Medicament Delivery Device
Gene Therapy
Macular Degeneration
Pompe Disease
Fluid Transfer Device
RNAi
Biomanufacturing
Antibody Detection
Ciliopathies
TRK Inhibitors
Flow Cytometry
Protein A Chromatography

823 patents:

1. 12735459 - MODIFIED ADENO-ASSOCIATED VIRAL CAPSID PROTEINS FOR OCULAR GENE THERAPY AND METHODS OF USE THEREOF (2026-09-15),
2. 12734307 - Medicament delivery device (2026-09-15),
3. 12734160 - Methods for treating symptoms and disorders associated with lysosomal storage diseases (2026-09-15),
4. 12691229 - Medicament delivery device (2026-07-28),
5. 12685307 - Ultra-high density cell banking methods (2026-07-21),
6. 12674003 - SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES (2026-07-07),
7. 12661305 - Vial adapter and injection kit for withdrawing a liquid medicament from an injection vial (2026-06-23),
8. 12661303 - Medical device for rolling and mixing a medicament within a medicament vial along a track (2026-06-23),
9. 12655200 - Methods of Treating Antibody-Mediated Disorders with FcRn Antagonists (2026-06-16),
10. 12649750 - Macrocyclic compounds, compositions, and methods of using thereof (2026-06-09),
11. 12642913 - Medicament delivery device (2026-06-02),
12. 12637653 - In-line product monitoring in integrated continuous bio-manufacturing (2026-05-26),
13. 12637414 - Arylamides and methods of use thereof (2026-05-26),
14. 12630810 - Polypeptide Having Beta-Hexosaminidase Activity, and Polynucleotides Coding for the Same (2026-05-19),
15. 12630521 - Arylamides and methods of use thereof (2026-05-19),
Genzyme Corporation is a biotechnology company focused on developing innovative therapies to address unmet medical needs. They specialize in rare genetic diseases, multiple sclerosis, oncology, immunology, and more. With a strong commitment to patients, Genzyme has been delivering life-changing treatments and advancing scientific research for over three decades.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Genzyme Corporation
823 Patents

#6 in Cambridge, MA

#36 in Massachusetts

#623 in US

#1,225 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Genzyme Corporation

Forward Citations = 15,471

957 inventors:

goldMedal Seng H Cheng (54 out of 71 patents)

silverMedal Craig S Siegel (41 out of 42 patents)

bronzeMedal Huawei Qiu (33 out of 47 patents)

4.  David J Harris (32 out of 32 patents)

5.  Clark Qun Pan (32 out of 56 patents)

Please report any incorrect information to [email protected]
Loading…